Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pentamidine
Drug ID BADD_D01717
Description Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
Indications and Usage For the treatment of pneumonia due to Pneumocystis carinii.
Marketing Status Prescription; Discontinued
ATC Code P01CX01
DrugBank ID DB00738
KEGG ID D00834
MeSH ID D010419
PubChem ID 4735
TTD Drug ID D05EAM
NDC Product Code Not Available
Synonyms Pentamidine | Pentamidin | Lomidine | NebuPent | Pentamidine Isethionate | Pentam | Pentamidine Mesylate | Diamidine | Pentacarinat
Chemical Information
Molecular Formula C19H24N4O2
CAS Registry Number 100-33-4
SMILES C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Stomatitis07.05.06.005--
Syncope17.02.04.008; 02.01.02.008; 24.06.02.012--
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.014--Not Available
Tension19.06.02.005--Not Available
Thrombocytopenia01.08.01.002--Not Available
Tonsillitis22.07.03.008; 11.01.13.006--Not Available
Torsade de pointes02.03.04.005--Not Available
Tremor17.01.06.002--
Tuberculosis11.04.01.006--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vasculitis10.02.02.006; 24.05.02.001--
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Cytomegalovirus chorioretinitis11.05.01.006; 06.04.06.009--Not Available
Respiratory tract congestion22.02.07.003--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Inappropriate antidiuretic hormone secretion14.05.07.001; 05.03.03.001--Not Available
Affect lability19.04.01.001--Not Available
Induration08.01.03.020--Not Available
Pneumonia bacterial22.07.06.004; 11.02.01.009--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Psychotic disorder19.03.01.002--
Renal impairment20.01.03.010--Not Available
Cytopenia01.03.03.012--Not Available
Oral herpes11.05.02.005; 07.05.07.002--Not Available
Acute kidney injury20.01.03.016--
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages